ArticleBioData mining2025
MediNet: ensemble transfer learning approach for classification of medical drugs-related text reviews using significant combined-embeddings.
Article in BioData mining, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This research work provides an innovative approach, called MediNet, for drug safety review classification that integrates the strengths of three word embedding approaches: FastText, ELMo, and GloVe, alongside an ensemble of EfficientNetB4 and MobileNet models. The unique blend of these word embeddings captures both context-independent and context-dependent representations, enabling the model to understand complex linguistic nuances within drug reviews. The ensemble architecture leverages EfficientNetB4's scalability and MobileNet's efficiency, making MediNet both powerful and resource-efficient. The proposed model MediNet is evaluated concerning performance on a comprehensive dataset of drug safety reviews, achieving remarkable results with a 95.69% accuracy, 96.46% precision, 98.30% recall, and 97.22% F1 score. The generalizability of MediNet is evaluated using the cross-validation technique, demonstrating the statistical significance of the results. Additionally, MediNet results are compared against six other well-known transfer learning models, where it consistently outperforms other models across all metrics. These results suggest that MediNet is a highly effective solution for classifying drug safety reviews, significantly improving accuracy and reliability compared to existing models. The proposed approach offers a promising direction for future research in natural language processing and its application to healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.